Fund Holdings — Finepoint Capital LP

Total Portfolio Value
$822.35M
Total Bought
$441.31M
Total Sold
$261.7K
Net Transaction
+$441.05M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q2 2024
▲▼
Q3 2024
▲▼
Change
▲▼
Q2 2024
▲▼
Q3 2024
▲▼
Weight (%)
▲▼
Change
▲▼
QXO INC(QXO)025,750,781+25,750,7810406,09049.38%+406,090
Liberty Broadband Corp(LBRDA)1,994,5101,994,5100109,339154,15618.75%+44,817
TRAVERE THERAPEUTICS INC(TVTX)1,776,7281,782,267+5,53914,60524,9343.03%+10,329
Argenx SE(ARGX)54,02854,428+40023,23429,5043.59%+6,270
REVOLUTION MEDICINES INC(RVMD)729,464731,960+2,49628,31033,1944.04%+4,884
GALAPAGOS NV(LKFT)542,762557,762+15,00013,45016,0581.95%+2,608
ASCENDIS PHARMA A/S(ASND)189,272190,072+80025,81328,3803.45%+2,567
MoonLake Immunotherapeutics(MLTX)388,835388,835017,09719,6052.38%+2,508
SOLID BIOSCIENCES INC961,251961,25105,4506,7000.81%+1,250
RELAY THERAPEUTICS INC(RLAY)1,605,3461,626,146+20,80010,46711,5131.40%+1,046
CALIDI BIOTHERAPEUTICS INC012,500+12,5000140.00%+14
Compass Digital Acquisition Corp459,906459,906028280.00%+1
Swiftmerge Acquisition Corp490,000490,000039390.00%0
Marblegate Acquisition Corp735,000735,000027250.00%-2
LAKESHORE BIOPHARMA CO LTD489,999489,999033240.00%-9
CALIDI BIOTHERAPEUTICS INC655,200655,20002890.00%-19
CALIDI BIOTHERAPEUTICS INC125,0000-125,000250—-25
MONEYHERO LIMITED
*W EXP 09/13/202
895,000895,000072270.00%-45
CONCORD ACQUISITION CORP II(CNDA)408,3330-408,333450—-45
CHURCHILL CAPITAL CORP VII548,0000-548,0001920—-192
CYTOKINETICS INC(CYTK)256,449256,449013,89413,5411.65%-354
EYEPOINT PHARMACEUTICALS INC(EYPT)707,404707,40406,1545,6520.69%-502
ACADIA PHARMACEUTICALS INC905,384905,384014,71213,9251.69%-788
ARVINAS INC(ARVN)574,378574,378015,29014,1471.72%-1,143
PROTHENA CORP PLC
SHS
433,471433,47108,9477,2520.88%-1,695
SPRINGWORKS THERAPEUTICS INC638,352650,852+12,50024,04720,8532.54%-3,193
SAREPTA THERAPEUTICS INC(SRPT)132,835133,535+70020,98816,6772.03%-4,311
Page 1 of 1
Finepoint Capital LP — 13F Holdings — Q3 2024 | TickerTrail